Back to Glossary
Regulatory Terms Starting With N
3 terms in the N index.
NDS (NDS)
NDS supports cross-functional regulatory execution across quality, clinical, and safety teams.
New Drug Application (NDA)
A formal request to the FDA for approval to market a new pharmaceutical drug in the United States.
Nitrosamine RISK Assessment
Nitrosamine RISK Assessment is a safety governance concept used to detect, evaluate, and mitigate post-market risks.